S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,116.57 +0.34%
Next Bullish Trade
Sign in
VEEV

Veeva Systems Inc. VEEV

$195.38 -1.99 (-1.01%)
Extended · +1.54σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · VEEV

Momentum reads · latest daily bar
Last
$195.38
-1.99 (-1.01%)
Mkt cap
$31.7B
Healthcare
RSI(14)
65.4
neutral
Stochastic %K
86.8
overbought
MFI(14)
78.8
neutral
ADX(14)
27.0
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-04-30 $0.9B $0.3B $0.3B $1.1B 29.6% 30.9%
2026-01-31 $0.8B $0.2B $0.2B $0.1B 29.2% 29.4%
2025-10-31 $0.8B $0.2B $0.2B $0.2B 29.1% 29.7%
2025-07-31 $0.8B $0.2B $0.2B $0.2B 25.4% 24.8%
2025-04-30 $0.8B $0.2B $0.2B $0.9B 30.1% 30.8%
2024-10-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare VEEV vs peers

Line VEEV up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing VEEV MRK× AAPL×
Verdict
Weighted score 0-100 across 3 tickers · best in green
#1
VEEV
score 53.2
5/5 inputs
Dominates with perfect growth score of 49 while maintaining strongest value metrics including PEG ratio of 0.88.
value 68growth 49quality 59momentum 34sentiment 55
#3
MRK
score 46.9
5/5 inputs
Zero growth score with no EPS growth data crushes overall rank despite strong 79 value rating.
value 79growth 0quality 42momentum 46sentiment 78
#2
AAPL
score 51.0
5/5 inputs
Perfect growth score of 100 with 21.8% EPS growth drives rank despite terrible value score of 14.
value 14growth 100quality 47momentum 77sentiment 0
VEEV
Veeva Systems Inc.
$195.38
-1.01%
Snapshot
Price 195.38
Day % -1.01
1M % 19.59
3M % 16.51
YTD % -10.98
Market cap 31738171392.0
ADV ($) 610400154.4747314
Beta 0.941
OdysseyHQ zone
Current zone Extended
Dist 21-EMA % 6.06
Dist ATR (σ) 1.54
OdysseyHQ grade B
Confluence 5
Valuation
P/E (ttm) 34.580532
P/E (fwd) 19.47036
P/S 9.561948
EV/EBITDA 23.904
P/B 4.358437
FCF yield 0.0397
PEG 0.88
Growth
Revenue yoy 0.163
EPS yoy 0.146
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.75021005
Operating margin 0.30932
Net margin 0.28370002
ROE 0.13934
ROA 0.07298
Debt / Equity 0.01
Interest cov.
Technicals
RSI(14) 65.4
MACD signal bull
vs 50-DMA 13.91
vs 200-DMA -6.51
vs 52w high -37.08
HV-30 43.5
Sentiment
Analyst rec 1.93103
Target upside 25.19
Insider buy-sell 90d 7
Risk
Short interest 5.0300002
Days to cover 2.49
Next earnings 2026-09-02
Full VEEV dashboard →
MRK
MRK
$127.50
-0.10%
Snapshot
Price 127.5
Day % -0.1
1M % 10.71
3M % 10.43
YTD % 19.77
Market cap 314902609920.0
ADV ($) 1319581140.0
Beta 0.205
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 2.82
Dist ATR (σ) 0.96
OdysseyHQ grade B
Confluence 3
Valuation
P/E (ttm) 36.01695
P/E (fwd) 13.203829
P/S 4.7880826
EV/EBITDA 12.141
P/B 6.863695
FCF yield 0.0446
PEG 11.81
Growth
Revenue yoy 0.049
EPS yoy
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.76725996
Operating margin 0.38604
Net margin 0.13586001
ROE 0.18944
ROA 0.12578
Debt / Equity 1.07
Interest cov. 16.52
Technicals
RSI(14) 57.9
MACD signal neutral
vs 50-DMA 6.67
vs 200-DMA 16.44
vs 52w high -3.22
HV-30 33.7
Sentiment
Analyst rec 1.82143
Target upside 5.13
Insider buy-sell 90d 40
Risk
Short interest 1.27
Days to cover 2.48
Next earnings 2026-08-04
Full MRK dashboard →
AAPL
Apple Inc.
$333.74
+0.14%
Snapshot
Price 333.74
Day % 0.14
1M % 11.53
3M % 26.7
YTD % 23.15
Market cap 4901757779968.0
ADV ($) 18299230656.54297
Beta 1.097
OdysseyHQ zone
Current zone Blow-off
Dist 21-EMA % 7.28
Dist ATR (σ) 2.78
OdysseyHQ grade
Confluence 1
Valuation
P/E (ttm) 40.502426
P/E (fwd) 34.625034
P/S 10.858001
EV/EBITDA 30.742
P/B 45.969696
FCF yield 0.0206
PEG 2.69
Growth
Revenue yoy 0.166
EPS yoy 0.218
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.47862
Operating margin 0.32275
Net margin 0.27152002
ROE 1.4147099
ROA 0.26229
Debt / Equity 0.8
Interest cov.
Technicals
RSI(14) 71.6
MACD signal bull
vs 50-DMA 10.27
vs 200-DMA 21.71
vs 52w high -0.37
HV-30 34.2
Sentiment
Analyst rec 2.0
Target upside -4.64
Insider buy-sell 90d -5
Risk
Short interest 0.9599999499999999
Days to cover 2.11
Next earnings 2026-07-30
Full AAPL dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-06-03 2.24 2.14 +4.9% -0.1%
2026-03-04 2.06 1.94 +6.5% +4.0%
2025-11-20 2.04 1.95 +4.5% -9.8%
2025-08-27 1.99 1.90 +4.8% -7.2%
2025-05-28 1.97 1.74 +13.0% +19.0%
2025-03-05 1.74 1.58 +10.1% +7.4%
2024-12-05 1.75 1.58 +10.7% +8.1%
2024-08-28 1.62 1.53 +5.6% +8.9%
2024-05-30 1.50 1.42 +5.3% -10.3%
2024-02-29 1.38 1.30 +6.2% -1.6%
2023-12-06 1.34 1.29 +3.7% -3.0%
2023-08-30 1.21 1.13 +7.3% +8.4%
2023-05-31 0.91 0.80 +13.6% +19.7%
2023-03-01 1.15 1.04 +10.6% +4.5%
2022-12-01 1.13 1.07 +5.3% -8.6%
2022-08-31 1.03 1.01 +1.9% -14.0%
2022-06-01 0.99 0.92 +7.3% +14.7%
2022-03-02 0.90 0.88 +2.0% -16.2%
2021-12-01 0.97 0.88 +10.6% -3.6%
2021-09-01 0.94 0.86 +9.0% -5.4%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
VEEV $32B 34.6 19.5 9.6 23.9 4.4 75.0% 16.3% 14.6% 3.97%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 33.18%

HolderShares% out
Blackrock Inc. 11,558,875 7.12%
Vanguard Portfolio Management LLC 7,376,031 4.54%
Vanguard Capital Management LLC 6,670,318 4.11%
Alliancebernstein L.P. 6,271,098 3.86%
Linonia Partnership LP 4,924,626 3.03%
Principal Financial Group, Inc. 4,141,545 2.55%
State Street Corporation 3,608,655 2.22%
T. Rowe Price Investment Management, 3,405,594 2.10%
Geode Capital Management, LLC 3,312,734 2.04%
FMR, LLC 2,613,526 1.61%

Insider activity · 90d

1 buys / 0 sells · ratio 1.0 · Finnhub

  • Zuppas Eleni Nitsa M 6,541
  • Zuppas Eleni Nitsa M 33,418
  • Van Wagener Brian M 4,906
  • Van Wagener Brian F 9,325 @ $184.22
  • Van Wagener Brian M 10,018
  • Schwenger Thomas D. M 8,721
  • Schwenger Thomas D. F 25,449 @ $184.22
  • Schwenger Thomas D. M 26,566
  • Kondath Vipin M 502
  • Kondath Vipin F 2,783 @ $184.22

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$165.0
Mean
$244.59259
High
$350.0
Analysts
27
Recommendation distribution · period 2026-07-01
8
17
9
1
Revision trend (2026-04-01 → 2026-07-01): net 28 → 24 -4 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-06 FORM 4 view ·
4 2026-07-06 FORM 4 view ·
4 2026-07-06 FORM 4 view ·
4 2026-07-06 FORM 4 view ·
4 2026-07-06 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
4 2026-06-22 FORM 4 view ·
8-K 2026-06-18 8-K view ·
10-Q 2026-06-05 10-Q view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
4 2026-06-03 FORM 4 view ·
8-K 2026-06-03 8-K view ·
4 2026-05-04 FORM 4 view ·
DEF 14A 2026-05-04 DEF 14A view ·
8-K 2026-04-20 8-K view ·
4 2026-04-14 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-09 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
4 2026-04-03 FORM 4 view ·
10-K 2026-03-20 10-K view ·
4 2026-03-09 FORM 4 view ·
8-K 2026-03-04 8-K view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-01-15 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
4 2026-01-05 FORM 4 view ·
8-K 2026-01-05 8-K view ·
4 2025-12-11 FORM 4 view ·
8-K 2025-12-11 8-K view ·
4 2025-12-03 FORM 4 view ·
4 2025-12-02 FORM 4 view ·

About VEEV

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which i…

Options picks · VEEV

ITM + OTM ideas from the latest scan

Loading…

Congress trades · VEEV

STOCK Act disclosures

Loading…

SEC filings & insiders · VEEV

EDGAR · live

Loading…

Holders · VEEV

Institutions & insider activity

Loading…